telomerase: 540-548 peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-017056
A recombinant peptide consisting of the amino acid residues 540 to 548 of the human telomerase reverse transcriptase (hTERT). Telomerase expression has been directly linked to tumor development; its catalytic subunit is expressed in the majority of human cancer cells, but infrequently in normal cells. Vaccination with telomerase:540-548 peptide may stimulate cytotoxic T cells to recognize and kill telomerase-expressing cells.
| Identifier | MLC-T-ONC-017056 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | TEL540-548 |
| Synonyms | Telomerase:540-548 Peptide |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017056",
"term": "telomerase: 540-548 peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A recombinant peptide consisting of the amino acid residues 540 to 548 of the human telomerase reverse transcriptase (hTERT). Telomerase expression has been directly linked to tumor development; its catalytic subunit is expressed in the majority of human cancer cells, but infrequently in normal cells. Vaccination with telomerase:540-548 peptide may stimulate cytotoxic T cells to recognize and kill telomerase-expressing cells.",
"abbreviation": "TEL540-548",
"synonyms": [
"Telomerase:540-548 Peptide"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/telomerase-540-548-peptide-vaccine/"
}
Record 16,127 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.